Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Pinpoint root causes, such as leakage or overspending, then implement targeted adjustments to regain monthly balance.
24,020 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Beijing and Hong Kong unveiled a coordinated package to deepen offshore yuan liquidity and gold settlement, signaling...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
A major capital shift is unfolding as chipmakers gain ground while hyperscalers slow. NVIDIA and Micron are set to be...
Warren Buffett unveils a sweeping update to his charitable giving, moving billions of dollars to four family-led foun...
Cantor Fitzgerald partners with Securitize to explore blockchain-native IPO shares, signaling a shift toward real-tim...
BMW is recalling 29,119 plug-in hybrid models due to an engine starter defect that could cause a fire. Regulators ind...
Carrington Mortgage Services is partnering with Kastle to deploy AI agents across its loan servicing operations, aimi...
Jim Cramer warned that semiconductor stocks could slide as margin selling weighs on the sector, pointing investors to...
A new staking-focused crypto ETF begins trading, promising 7% yield through Ethereum staking and easy access via a st...
Equifax will keep VantageScore 4.0 at $1 through 2027, a move that could reshape mortgage lending as lenders race to ...
Arweave's AR token is in focus as investors map a path for 2025 through 2030. This piece outlines the key drivers, sc...